Study of Azacitidine Combined With Homoharringtonie Based Regimens in AML

Clinical trial NCT04248595 · UNKNOWN

Trial details

NCT number: NCT04248595
Sponsor: Ge Zheng
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Myeloid Leukemia

Start date: 2019-12-01
Primary completion: 2022-09-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.